Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS (FDA Adverse Event reporting System) database

COMMENTED

Retinal Diseases

Ocular Outcomes with Tirzepatide Versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Ophthalmol Retina

Hong AT, Lin F, Keenan JD, Stewart JM

doi: 10.1016/j.oret.2026.02.002

Retinal Diseases

Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study

Diabetes Obes Metab

Lavens A, De Block C, Oriot P, Philips JC, Vandenbroucke M, Crenier L, Nobels F, Mathieu C, Belgian Group of Experts IQED

doi: 10.1111/dom.70049

COMMENTED

Further Publications

Association Between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy: A Meta-analysis

★ 2 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Diabetes Care

Nogueira A, Rassi TNO, Iqbal A, Felix N, Alghaith O, Khan A, Rassi N, Maia M, Moura FA

doi: 10.2337/dc25-1238

Retinal Diseases

Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial

JAMA Ophthalmol

Sasako T, Ueki K, Miyoshi K, Miyake K, Aoyama T, Okazaki Y, Ishizuka N, Yamauchi T, Noda M, Kadowaki T, J-DOIT3 Study Group

doi: 10.1001/jamaophthalmol.2025.3819

COMMENTED

Retinal Diseases

Relationship between free fatty acids and diabetic retinopathy in male patients with type 2 diabetes

★ 2 Recommended and commented by Prof. emer. Dr Josef Flammer, Faculty Member

Sci Rep

Chen J, Huang Y, Liu C, Chi J, Xu L, Wang Y

doi: 10.1038/s41598-025-07001-w

Retinal Diseases

Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand

Pediatr Diabetes

Winter T, Derraik JGB, Jefferies CA, Hofman PL, Shand JAD, Braatvedt GD, Misra SL

doi: 10.1155/2024/5893771

COMMENTED

Uveitis

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Uveitis

★ 2 Recommended and commented by Prof. emer. Dr Josef Flammer, Faculty Member

JAMA Ophthalmol

Mohan N, Srivastava SK, Schulgit MJ, Nowacki AS, Kaelber DC, Sharma S

doi: 10.1001/jamaophthalmol.2025.2822

Macular Diseases

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration

JAMA Ophthalmol

Shor R, Mihalache A, Noori A, Shor R, Kohly RP, Popovic MM, Muni RH

doi: 10.1001/jamaophthalmol.2025.1455

COMMENTED

Further Publications

New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

JAMA Ophthalmol

Heberer K, Bress AP, Cogill S, Maldonado AI, Kim SH, Nallamshetty S, Chen YQ, Shih MC, Lynch JA, Lee JS

doi: 10.1001/jamaophthalmol.2025.6262

Related content

Ocular Outcomes with Tirzepatide Versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes

Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study

Association Between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy: A Meta-analysis

Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial

Relationship between free fatty acids and diabetic retinopathy in male patients with type 2 diabetes

Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Uveitis

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration

New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes